APA (7th ed.) Citation

Shcherbyna, R. O., Khromylova, O. V., Nimenko, H. R., & Salionov, V. O. (2024). Development of the optimal composition of tablets with the active substance potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate. Message 1. Study of the effect of auxiliary substances on bulk density, bulk density after shrinkage, fluidity and angle of natural slope of powder masses. Zaporizhzhia State Medical and Pharmaceutical University.

Chicago Style (17th ed.) Citation

Shcherbyna, R. O., O. V. Khromylova, H. R. Nimenko, and V. O. Salionov. Development of the Optimal Composition of Tablets with the Active Substance Potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate. Message 1. Study of the Effect of Auxiliary Substances on Bulk Density, Bulk Density After Shrinkage, Fluidity and Angle of Natural Slope of Powder Masses. Zaporizhzhia State Medical and Pharmaceutical University, 2024.

MLA (9th ed.) Citation

Shcherbyna, R. O., et al. Development of the Optimal Composition of Tablets with the Active Substance Potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate. Message 1. Study of the Effect of Auxiliary Substances on Bulk Density, Bulk Density After Shrinkage, Fluidity and Angle of Natural Slope of Powder Masses. Zaporizhzhia State Medical and Pharmaceutical University, 2024.